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Background: The objective of this study was to evaluate the mediating role of maternal early pregnancy plasma
levels of long chain polyunsaturated fatty acids (LCPUFAs) in the association of interpregnancy interval (IPI) with
birth weight and smallness for gestational age (SGA) at birth.
Methods: We analysed a subsample of the Amsterdam Born Children and their Development (ABCD) cohort,
comprising 1,659 parous pregnant women recruited between January 2003 and March 2004. We used linear and
logistic regression to evaluate the associations between fatty acid status, interpregnancy interval and pregnancy
outcome.
Results: Low plasma phospholipids concentrations of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA)
and dihomo-gamma-linolenic acid (DGLA), and high concentrations of arachidonic acid (AA) during early
pregnancy were associated with reduced birth weight and/or an increased risk of SGA. Short IPIs (< 6 months, with
18–23 months as a reference) were associated with a mean decrease of 207.6 g (SE: ± 73.1) in birth weight (p =
0.005) and a twofold increased risk of SGA (OR: 2.05; CI: 0.93–4.51; p = 0.074). Adjustment for maternal fatty acid
concentrations did not affect these results to any meaningful extent.
Conclusions: Despite the observed association of maternal early pregnancy LCPUFA status with birth weight and
SGA, our study provides no evidence for the existence of an important role of maternal EPA, DHA, DGLA or AA in
the association of short interpregnancy intervals with birth weight and SGA.Background
Interpregnancy intervals (IPIs) shorter than six months are
linked with increased risks of preterm birth, lower birth
weight and smallness for gestational age (SGA) [1-3].
These adverse pregnancy outcomes are associated with
perinatal and neonatal morbidity and mortality and can
affect later development and health [4]. Long-term effects
have also been described, including increased risks of
schizophrenia, menstrual disorders and subfecundity [5-7].
The mechanisms underlying the unfavourable effects
of short IPIs on pregnancy outcomes are not well under-
stood. Some causal hypotheses have been put forward,
including postpartum hormonal imbalance, maternal
stress and the maternal nutritional depletion hypothesis
[8-10]. The latter hypothesis states that women with* Correspondence: luc.smits@epid.unimaas.nl
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reproduction in any medium, provided the orclosely spaced births have insufficient time to restore the
nutritional reserves needed to support fetal growth in
the subsequent pregnancy, resulting in an increased risk
of unfavourable pregnancy outcome. Nutrients of inter-
est in the nutritional depletion hypothesis have to meet
several criteria: (1) they have to be necessary in preg-
nancy and fetal development, with shortage leading to
an adverse pregnancy outcome; (2) their maternal func-
tional status should decline during pregnancy; and (3)
their normalisation to a sufficient concentration after
pregnancy has to be slow. The micronutrients folate and
iron fit this profile [11,12]. Indeed, in a recent study, the
association between short interpregnancy interval and
pregnancy outcome was found to be stronger among
women with low periconceptional folic acid supplement
intake [13].
Nutrients that could play a similar role in the relation-
ship between short interpregnancy interval and adversetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Women invited
8,266 Returned questionnaire
7,738 Delivered viable singleton
Information on birth weight and pregnancy
duration was available
3,335 Multiparous pregnancy and term delivery
1,679
Known information on interpregnancy interval
Known information on fatty acid status
1,659
12,373
Figure 1 Selection of the study sample.
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ated derivatives of the essential fatty acids α-linolenic acid
and linoleic acid, also known as long chain polyunsatur-
ated fatty acids (LCPUFAs). This particularly holds
for docosahexaenoic acid (DHA, 22:6n-3), eicosapenta-
enoic acid (EPA, 20:5n-3), arachidonic acid (AA, 20:4n-6)
and its precursor, dihomo-gamma-linolenic acid (DGLA,
20:3n-6), which are structural components of cell
membranes and are involved in a range of physiologic
processes relevant to fetal growth, development and im-
mune system [14-17]. Consequently, a shortage of any of
these essential fatty acids could result in a less favourable
pregnancy outcome.
A decrease in biochemical LCPUFA status is common
in pregnant women [18,19]. This is probably explained by
fetal needs during development, since the developing fetus
completely depends on the maternal essential fatty acids
supply [20]. Complete recovery after delivery takes more
than six months [18,21]. A lower absolute (mg/L plasma)
and relative (% of total fatty acids) amount of DHA in ma-
ternal plasma phospholipids during pregnancy was seen in
multigravids compared to primigravids [22], suggesting in-
complete recovery of maternal DHA availability after de-
livery [23]. Low concentrations of most n-3 fatty acids,
including DHA, and high concentrations of AA are
associated with lower birth weight and/or higher SGA risk
[24,25].
In the present study, we evaluated the potential role of
the concentrations of DHA, AA, DGLA and EPA in the
relationship between interpregnancy interval and adverse
pregnancy outcome in a population-based cohort of
1,659 multiparous pregnant women.
Methods
Population and design
Data for this study were obtained from the Amsterdam
Born Children and their Development (ABCD) study. This
prospective, population-based cohort study examined the
relationship between maternal lifestyle, ethnicity, psycho-
social conditions and nutritional status during pregnancy
and the child’s health at birth and in later life (www.abcd-
study.nl). The study design has been described in detail
elsewhere [24]. In short, between January 2003 and March
2004, pregnant women living in Amsterdam were invited
to enrol in the study during their first antenatal visit to
their obstetric care provider. Detailed information about
the mother's socio-demographic data, obstetric history,
lifestyle, dietary habits and psychosocial factors was
collected by the use of questionnaires, which were avail-
able in multiple languages. As part of a biomarker study,
blood was drawn after the first prenatal visit to assess the
level of fatty acids.
Of the 12,373 pregnant women invited to participate,
8,266 returned the questionnaire (response rate, 67%).Of this group, 7,738 women gave birth to a single live in-
fant about whom information on birth weight and preg-
nancy duration was available. For the present study, we
excluded all primiparous women (n = 3,993) and women
who delivered preterm (delivery before 37 complete weeks
of gestation, n = 410). In addition, we excluded 1,656
women (49.9%) who did not participate in the biomarker
study and therefore lacked data on fatty acid status, as well
as 20 women for whom the interpregnancy interval was
not known. Consequently, data about 1,659 women and
their infants were available for analysis (see Figure 1).
Study approval was obtained from the Central Com-
mittee on Research Involving Human Subjects in the
Netherlands, the medical ethical committees of partici-
pating hospitals and the Registration Committee of
Amsterdam. Written informed consent was obtained
from all participants.
Main variables
Primary outcome variables were birth weight (in grams)
and SGA, which was defined as birth weight below the
10th percentile for gestational age based on sex- and parity
-specific standards from the Dutch Perinatal Registry
(available from the authors upon request). Gestational age
at birth was determined by ultrasound (i.e. fetal biometry)
or, if unavailable (< 10%), based on the first day of the last
menstrual period.
Interpregnancy interval was computed as the amount
of time between current and previous delivery dates,
diminished by the duration of the current pregnancy.
We divided interpregnancy interval into five categories;
< 6, 6–11, 12–17, 18–23 and ≥ 24 completed months,
and used 18–23 months as the reference category [1,3].
Infant sex, birth weight and gestational age at birth (in
weeks) were obtained from the Youth Health Department
of the Public Health Service in Amsterdam. The date of
the previous delivery was collected via questionnaire.
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described [24]. In short, phospholipids isolated from
plasma were saponified and the resulting fatty acids were
methylated and measured by capillary gas chromatography
with flame ionisation detection. The absolute amounts of
arachidonic acid (20:4 n-6), docosahexaenoic acid (22:6 n-
3) dihomo-gamma-linolenic acid (20:3 n-6) and eicosa-
pentaenoic acid (20:5 n-3) (in mg/L plasma) were quanti-
fied on the basis of the recovery of an internal standard
and expressed in a relative value (percentage of total
amount of phospholipids-associated fatty acids).
Potential confounders
A number of variables were considered and treated as
potential confounders. Maternal age in years [26] (< 25,
25–34 or ≥ 35), parity [27] (1, 2 or ≥ 3), height [27] (in
cm) and pre-pregnancy BMI [27] (in kg/m2) were
obtained from the questionnaire. A random imputation
procedure using linear regression analysis on the avail-
able variables was used to complete missing data on
height (3.4% missing) and weight (9.5% missing) [24].
Maternal pregnancy-related variables were pregnancy
intention (by inquiring whether participants did or did
not want to become pregnant) [28], spontaneous preg-
nancy (by inquiring whether participants became preg-
nant with or without any medical intervention) [29],
time to pregnancy (time needed to become pregnant; <
3, 3–12 or ≥ 12 months) [30] and start of prenatal care
in weeks of gestation as calculated from the date of the
first prenatal visit, the date of birth and gestational age
at birth (<18, 18–23 or ≥24).
Lifestyle variables included self-reported smoking
habits [31] and alcohol consumption [32,33] (yes/no) be-
fore and/or during pregnancy and psychosocial stress
(presence of 0, 1 or ≥ 2 stressors) [34]. Stressors were
measured by validated Dutch versions of internationally
used questionnaires on depression [35], general anxiety
[36], pregnancy-related anxiety [37], parenting stress
[38] and work stress [39]. Because there are no inter-
nationally accepted thresholds for non-normal scores in
pregnant women, we set them at the 90th percentile.
Finally, the selected socio-demographic factors were co-
habitant status (living with a partner or living alone) [40],
years of education after primary school (< 6, 6–10 or ≥ 11
years) [41] and ethnicity. Ethnicity was determined by
asking about the respondent’s country of birth and that of
her mother (the Netherlands, Surinam, Turkey, Morocco
or other) [42]. All the variables were measured by ques-
tionnaire, unless mentioned otherwise.
Statistical analyses
We examined the relationship between maternal LCPUFA
concentrations and pregnancy outcome by means of logis-
tic regression (SGA) and linear regression (birth weight).Because we expected potential associations in the extreme
values [24], we used quintiles to categorise the maternal
plasma phospholipids concentration of each LCPUFA of
interest. The middle category was used as a reference. To
examine the relationship between IPI and maternal
LCPUFA concentrations, we designated the quintile with
the strongest association with adverse pregnancy outcome
as the least favourable quintile. We then performed a lo-
gistic regression to evaluate whether IPI was associated
with being in the least favourable LCPUFA quintile (versus
any other LCPUFA quintile).
To evaluate the association between IPI and pregnancy
outcome, we performed a logistic regression analysis (SGA)
and a linear regression analysis (birth weight). Confounding
factors were evaluated by performing multivariate, adjusted
analyses in which each of the above-mentioned covariates
was separately added to the model. In the SGA analyses, in-
fant sex and gestational age were omitted from the multi-
variate analyses since they were already part of the
definition of SGA. In the logistic regression analyses, a
covariate was considered to be a confounder when the odds
ratio of the univariate analyses deviated more than 10%
after adding that specific covariate. In the linear regression
analyses, we regarded a covariate to be a confounder when
the deviation of the regression coefficient was greater than
10%. Using this confounder selection strategy, none of the
aforementioned factors were identified as confounders, and
therefore the final multivariate model only contained
interpregnancy interval as an independent variable.
Finally, we assessed the potential influence of maternal
LCPUFA concentrations on the relationship between
interpregnancy interval and pregnancy outcome by
repeating the adjusted logistic and linear regression ana-
lyses. In these analyses, LCPUFAs were treated as inde-
pendent variables, first each LCPUFA separately and
then all LCPUFAs simultaneously. Associations were
considered statistically significant at p < 0.05. All ana-
lyses were conducted with the use of SPSS software (ver-
sion 15.0; SPSS Inc., Chicago, IL).
Results
Characteristics of the woman-infant pairs (n = 1659) are
presented in Table 1. The mean (± SD) infant birth weight
was 3,594 g (± 505), and the mean gestational age at birth
was 40.0 ± 1.2 weeks. In total, 12.4% of the infants were
born SGA. Of all the included women, 3.6% (n = 60) be-
came pregnant within six months after their previous de-
livery. Almost half of the women (49.4%; n = 820) had an
IPI of more than 24 months, and 13.5% (n = 223) became
pregnant again between 18 and 23 months.
Maternal essential fatty acids and pregnancy outcome
Blood samples for fatty acid analyses were taken at an aver-
age gestational age of 13.8 (± 3.5) weeks. Characteristics of




Birth weight in g (mean ± SD) 3594 ± 505








≥ 24 mo 49.4
Age (%)
< 25 y 5.7
25-34 y 61.2





Height in cm (mean ± SD) 168.5 ± 7.2
Prepregnancy BMI in kg/m2 (mean ± SD) 23.4 ± 4.1
Unintended pregnancy (%) 7.2
Non-spontaneous pregnancy (%) 1.9
Time to pregnancy (%)
<3 mo 64.9
3-12 mo 26.4
≥ 12 mo 8.7
Started prenatal care (%)
< 18 wk 92.1
18-23 wk 6.0
≥ 24 wk 1.9
Alcohol consumption (%)
None 41.2
Yes, but not since pregnancy 32.5
Yes, also during pregnancy 26.3
Smoking (%)
None 81.3
Yes, but not since pregnancy 10.2





Table 1 Maternal and infant characteristics (n=1659)
(Continued)




≥ 11 y 38.8





Other non-Western country 11.6
Other Western country 6.0
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biomarker study (n = 1,656, data not shown) were com-
parable to those of the women and infants who did.
The distributions of quintiles of maternal fatty acid
concentrations in plasma phospholipids are listed in
Table 2. Compared to infants born to women with inter-
mediate concentrations, infants born to women with
concentrations classified in the lowest quintile of EPA,
DHA or DGLA weighed 118–183 g less at birth (Table 3).
These infants were also more likely to be born SGA, al-
though this association was not statistically significant
for DHA.
A statistically significant association between maternal
AA concentrations and birth weight and SGA was also
present. Women with AA concentrations in the highest
quintile gave birth to infants with birth weights 145.0 g (SE:
39.1) lower and a nearly two times increased chance of
SGA in comparison with women with AA concentrations
in the middle quintile (OR = 1.88 (95% CI: 1.19–2.95).
Interpregnancy interval and maternal LCPUFA
concentrations
We did not observe any statistically significant associations
between short interpregnancy intervals and maternal
LCPUFA concentrations (Table 4). Compared to women
with an IPI of 18–23 months, mothers with long IPIs (≥ 24
months) had a significantly higher probability of having
lower EPA and higher AA concentrations in their plasma
phospholipids during the first trimester.
Table 2 Concentration of the selected fatty acids by quintile in maternal plasma phospholipids at early pregnancy1
Fatty acid Value Quintile
Mean ± SD Q1 Q2 Q3 Q4 Q5
Concentration total fatty acid (mg/L) 1451.81± 246.55 <1246.71 1246.71-1383.61 1383.61-1500.71 1500.71-1639.51 ≥1639.51
Concentration specific fatty acid2
EPA (20:5 n-3) 0.63 ± 0.45 < 0.33 0.33-0.46 0.46- 0.58 0.58 -0.81 ≥ 0.81
DHA (22:6 n-3) 4.07 ± 1.12 <3.74 3.74-4.35 4.35-4.86 4.88-5.54 ≥ 5.54
DGLA (20:3 n-6) 3.45 ± 0.75 < 2.83 2.83-3.23 3.23- 3.56 3.56- 4.05 ≥ 4.05
AA (20:4 n-6) 9.48 ± 1.68 < 8.06 8.06- 8.99 8.99- 9.83 9.83-10.86 ≥ 10.86
1 n=1659; Blood assessment in early pregnancy at an average pregnancy duration of 13.5 ±3.3 weeks of gestation. EPA, eicosapentaenoic acid (20:5 n-3); DHA,
docosahexaenoic acid (22:6 n-3), DGLA; dihomo-γ-linolenic acid (20:3 n-6), AA; arachidonic acid (20:4 n-6).
Table 3 Results of the regression analyses relating essential fatty acid concentrations in quintiles and pregnancy
outcome, defined as small for gestational age SGA and birth weight 1
Fatty acid Birth Weight (g) SGA
Mean ± SD Beta ± SE2 % of women with SGA birth within quintile Odds ratio (95% CI)3
EPA
Q1 3595 ± 536 −182.5 ± 39.04 12.7 2.09 (1.32-3.30) 4
Q2 3579 ± 542 −66.1 ± 39.0 13.3 1.42 (0.88-2.31)
Q3 3645 ± 474 0.0 9.7 1.00
Q4 3664 ± 498 18.4 ± 38.9 9.6 0.98 (0.59-1.64)
Q5 3619 ± 489 −26.6 ± 39.0 10.8 1.13 (0.68-1.87)
DHA
Q1 3518 ± 520 −118.2 ± 39.24 13.3 1.11 (0.70-1.75)
Q2 3593 ± 539 −43.8 ± 39.2 12.7 1.05 (0.66-1.67)
Q3 3636 ± 505 0.0 12.1 1.00
Q4 3602 ± 471 −34.4 ± 39.2 11.7 0.96 (0.60-1.54)
Q5 3621 ± 484 −15.4 ± 39.2 12.0 0.99 (0.62-1.59)
DGLA
Q1 3467 ± 472 −127.1 ± 38.94 17.2 1.72 (1.10-2.69)4
Q2 3610 ± 520 16.5 ± 38.9 14.8 1.43 (0.90-2.26)
Q3 3594 ± 531 0.0 10.8 1.00
Q4 3634 ± 495 40.0 ± 38.9 11.5 1.07 (0.66-1.74)
Q5 3665 ± 486 71.0 ± 38.9 7.5 0.67 (0.39-1.15)
AA
Q1 3606 ± 507 −52.8 ± 39.1 10.8 1.07 (0.65-1.76)
Q2 3617 ± 501 −42.2 ± 39.1 9.7 0.94 (0.57-1.57)
Q3 3659 ± 482 0.0 10.2 1.00
Q4 3574 ± 533 −85.0 ± 39.04 13.5 1.37 (0.86-2.21)
Q5 3514 ± 494 −145.0 ± 39.14 17.6 1.88 (1.19-2.95)4
1 Linear regression analysis with birth weight as dependent variable and fatty acid concentration as independent variable. n=1659 mother-infant pairs. Q1 to Q5
represents the quintile distribution of the relative concentrations given in Table 3. EPA, eicosapentaenoic acid (20:5 n-3); DHA, docosahexaenoic acid (22:6 n-3),
DGLA; dihomo-γ-linolenic acid (20:3 n-6), AA; arachidonic acid (20:4 n-6). The middle quintile, Q3, used as reference category.
2 Difference between the mean birth weight in the specific quintile and that of the reference quintile.
3 Odds ratio (95% CI).
4 p<0.05.
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Table 4 Results of the logistic regression analysis of the association between interpregnancy interval and unfavorable maternal essential fatty acid status
Interpregnancy
interval (mo)

































< 6 60 23.3 0.66 ± 0.47 1.58
(0.79-3.17)
18.3 4.77 ± 1.20 1.60
(0.51-2.22)
25.0 3.30 ± 0.69 1.22
(0.62-2.37)
25.0 9.34 ± 1.71 1.09
(0.52-2.29)
6-11 276 11.2 0.68 ± 0.44 0.66
(0.39-1.10)
18.3 4.70 ± 1.08 1.12
(0.71-1.77)
22.8 3.41 ± 0.75 1.08
(0.71-1.65)
21.7 9.28 ± 1.56 0.97
(0.52-2.29)
12-17 280 11.8 0.67 ± 0.38 0.69
(0.42-1.16)
19.2 4.85 ± 1.08 0.81
(0.50-1.31
17.9 3.54 ± 0.74 0.79
(0.51-1.23)
21.1 9.28 ± 1.47 0.79
(0.49-1.28)
18-23 223 16.1 0.70 ± 0.53 1 (ref) 14.6 4.75 ± 1.13 1 (ref) 21.5 3.40 ± 0.70 1 (ref) 22.9 9.35 ± 1.72 1 (ref)
≥ 24 820 26.6 0.58 ± 0.45 1.88
(1.28-2.78)
17.3 4.57 ± 1.14 1.40
(0.96-2.06)
18.9 3.46 ± 0.77 0.85
(0.59-1.22)
17.9 9.66 ± 1.76 1.53
(1.04-2.25)
Total 1659 0.63 ± 0.45 4.67 ± 1.12 3.45 ± 0.75 9.48 ± 1.68
1 EPA, eicosapentaenoic acid (20:5 n-3); DHA, docosahexaenoic acid (22:6 n-3), DGLA; dihomo-γ-linolenic acid (20:3 n-6), AA; arachidonic acid (20:4 n-6).
2 Odds ratios resulting from logistic regression analysis of the association of interpregnancy interval with having an unfavorable blood concentration of either of four essential fatty acids. For each fatty acid, the




















Table 5 Results of regression analyses of interpregnancy interval and pregnancy outcome (birth weight and SGA)
adjusted for maternal LCPUFAs concentrations in early pregnancy1
Interpregnancy
interval (mo)





n Mean ±SD Beta ± SE Beta ± SE Percentage (%) Odds ratio (95%CI) Odds ratio (95%CI)
<6 60 3500 ± 489 −206.7 ± 73.13 −193.4 ± 72.13 18.3 2.05 (0.93-4.51) 1.92 (0.86-4.28)
6-11 276 3628 ± 478 −78.5 ± 45.3 −84.1 ± 44.8 9.1 0.91 (0.50-1.66) 0.93 (0.51-1.72)
12-17 280 3613 ± 483 −94.1 ± 45.14 −115.0 ± 44.6 9.3 0.94 (0.52-1.70) 0.93 (0.51-1.72)
18-23 223 3707 ± 499 1.0 1.0 .9.9 1.00 1.00
≥24 820 3552 ± 519 −154.7 ± 38.03 −135.4 ± 37.83 14.8 1.58 (0.98-2.56) 1.43 (0.88-2.33)
1 Linear regression analysis for birth weight as dependent variable and interpregnancy interval in categories as independent variable; logistic regression analysis
for SGA as dependent and interpregnancy interval in categories as independent variable. SGA was defined as birth weight < 10th percentile for gestational age
based on sex- and parity-specific standards. n=1659 mother-infant pairs. None of the selected maternal and infant characteristics acted as confounding factors.
2 Analysis adjusted for all four selected fatty acids together.
3 Significantly different from reference category (18–23 mo) p<0.005.
4 Significantly different from reference category (18–23 mo) p<0.05.
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Both short (< 6 months) and long (≥ 24 month) IPIs
were significantly associated with lower birth weight
(Table 5). The short interval category showed an
estimated difference in birth weight of −206.7 g (SE:
± 73.1) compared to the reference category (18–23
months). We also observed a corresponding increase
in SGA risk, though this was not statistically significant.
Women with an IPI of less than six months were twice
as likely to deliver an SGA child than women who be-
came pregnant 18–23 months after their previous de-
livery (OR: 2.05; 95% CI: 0.93, 4.51). None of the
selected maternal and infant characteristics acted as
confounding factors.
Role of maternal essential fatty acid status in the
relationship between interpregnancy interval and
pregnancy outcome
After adjusting for each LCPUFA separately, the regres-
sion analyses on interpregnancy interval and birth weight/
SGA did not show any important changes in regression
coefficients or in odds ratios. When the four selected fatty
acids were adjusted for simultaneously, there was no
meaningful change in the observed relationships either
(Table 5). Results were not materially different when
LCPUFA variables were entered as quintiles instead of
continuous variables (results not displayed).
Discussion
This study examined the potential role of maternal
LCPUFA status during early pregnancy in the association
between short interpregnancy intervals with birth weight
and SGA. Our results showed an association between IPIs
of less than six months (and ≥ 24 months) and adverse
pregnancy outcome (Table 5). These findings correspond
to earlier observations within the ABCD cohort on therelationship between folate, interpregnancy interval and
birth weight, [13] as well as with the findings of a meta-
analysis of studies of the effects of short IPIs [1].
Our analyses of the relationship between maternal es-
sential fatty acids and pregnancy outcome (Table 3)
showed an increased risk of lower birth weight and/or
SGA in women with low EPA, DHA and DGLA plasma
phospholipids concentrations during early pregnancy.
For AA, on the contrary, higher concentrations were
associated with lower mean birth weights and increased
risk of SGA. These results correspond with earlier
observations in the ABCD cohort including nulliparas
[24]. A recent study of 782 women by Dirix et al. [25]
described a relationship between increased birth weight
and increased DHA concentrations measured in mater-
nal plasma phospholipids in early pregnancy. The
authors also reported that birth weight decreased as AA
contents increased in late pregnancy. In contrast to our
results, their findings on DGLA concentrations were in
the same line as AA, with a negative association between
maternal concentrations at delivery and birth weight.
Our analyses of interpregnancy interval and maternal
LCPUFA concentrations did not reveal any meaningful
associations between IPIs and individual LCPUFA
concentrations (Table 4). In particular, no significant
associations were observed for IPIs shorter that six
months which have been shown (here and in other ana-
lyses) to be associated with adverse pregnancy outcomes.
To our knowledge, the association between short IPI
and LCPUFA status during a new pregnancy was not
examined before. Findings from a study conducted by Al
et al. [18] on maternal essential fatty acid and LCPUFA
patterns during and after pregnancy imply a ‘recovery
time’ of at least six months for the biochemical DHA
status to normalise after pregnancy. Our results, how-
ever, indicated that fatty acid status as measured during
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or intermediate interpregnancy intervals.
After adjusting for the selected maternal LCPUFA
concentrations, we did not observe any meaningful changes
in the relationship between interpregnancy interval and
birth weight and/or risk of SGA (Table 5). The results of
this study therefore do not support the hypothesis that ma-
ternal DGLA, AA, EPA or DHA concentrations during
early pregnancy play an important role in the relationship
between short IPI and adverse pregnancy outcome. This is
likely due to the lack of association between short IPIs and
maternal LCPUFA concentrations during early pregnancy.
Although 50% of the potential study population was
excluded because of a lack of information on their fatty
acid concentrations, a comparison of maternal and infant
characteristics between included and excluded participants
indicated that the resulting study population was repre-
sentative for all. Because of a potential lack of power, we
also decided not to investigate less common outcomes
such as preterm birth (n = 64, 3.9%) or infant death. Since
this study focused on birth weight and SGA, which are
clinically relevant outcome measures, restricting the study
to term-born infants made it possible to investigate birth
weight as a reflection of health outcomes without the
distorting effect of preterm delivery [43].
None of the preselected maternal and infant covariables
acted as confounders in the association between IPI and
birth weight/SGA. However, we cannot exclude the possibil-
ity of residual confounding due to unmeasured confounders
or misclassification as a result of recall problems.
Measurement of essential fatty acid and LCPUFA
concentrations in early pregnancy reflects the potential
shortage due to a short interpregnancy interval. Moreover,
this early stage of pregnancy is vitally import for fetal de-
velopment [17,44,45] and is places a great demand on ma-
ternal nutrients. Although much is known about the
essence and biological function of essential fatty acids in
human life and pregnancy, we are still lacking basic infor-
mation such as the range of ‘healthy’ concentrations of
every fatty acid. Therefore, we chose to use the quintile
found to be associated with the highest risk of adverse
pregnancy outcome for the analysis of the influence of the
selected LCPUFA concentration (quintile) on the relation-
ship between IPI and birth weight and risk of SGA.
Conclusion
In conclusion, the study results do not support the idea that
maternal early pregnancy DHA, AA, EPA or DGLA levels
play an important role in the maternal depletion hypothesis.
Although maternal supplementation may be beneficial for
individual cases, based on the results of the current study
we do not expect that routine periconceptional maternal
fatty acid supplementation will mitigate the adverse effects
of short IPIs on pregnancy outcomes.Competing interests
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